Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in the Era of Systems Medicine

Immunology and Microbiology

• Skin 100%
• Mortality 100%
• Cells 50%
• Keratinocyte 50%
• Cytokine 50%
• Interferon Type I 50%
• Immunity 50%
• Recognition 50%
• Cytotoxicity 50%
• Tumor Necrosis Factor Alpha 50%
• Interleukin 15 50%
• Mediator 50%
• Perforin 50%
• Granzyme B 50%
• Consensus 50%
• Ciclosporin 50%
• T Cell Receptor 50%
• Morbidity 50%
• Human Leukocyte Antigen 50%
• Fas Ligand 50%
• Cytotoxic T Cell 50%
• TNF Inhibitor 50%
• Granulysin 50%
• Drug Hypersensitivity 50%
• Cytotoxic Factor 50%

Medicine and Dentistry

• Syndrome 100%
• Toxic Epidermal Necrolysis 100%
• Systems Medicine 100%
• Therapeutic Procedure 25%
• Mortality 25%
• Cells 12%
• Cytotoxicity 12%
• Cytokine 12%
• Disease 12%
• Tumor Necrosis Factor 12%
• Skin 12%
• Interferon 12%
• Drug 12%
• Chemotherapeutic Agent 12%
• Pathogenesis 12%
• Keratinocyte 12%
• Morbidity 12%
• Recognition 12%
• Placebo 12%
• Corticosteroid 12%
• Drug Therapy 12%
• Consensus 12%
• Sequela 12%
• Interleukin 15 12%
• Cyclosporine 12%
• Mediator 12%
• T Lymphocyte Receptor 12%
• Granzyme B 12%
• Human Leukocyte Antigen 12%
• Synapse 12%
• Cytotoxic T-Cell 12%
• Supportive Care 12%
• Perforin 12%
• Adverse Drug Reaction 12%
• Skin Necrosis 12%
• Cytotoxic Factor 12%
• Granulysin 12%
• TNF Inhibitor 12%
• Fas Ligand 12%